Daiichi Life Group announced on June 22, 2026, the issuance of 269,800 shares and 473,000 shares of new stock as part of its equity compensation program, raising approximately 130 million yen. The Board of Directors approved the introduction of the program to incentivize executives and enhance corporate value.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"8750","jir_company_name":"Daiichi Life Group Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-06-22","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/06\/8750-20260622-01.pdf","jir_short_summary":"Daiichi Life Group announced on June 22, 2026, the issuance of 269,800 shares and 473,000 shares of new stock as part of its equity compensation program, raising approximately 130 million yen. The Board of Directors approved the introduction of the program to incentivize executives and enhance corporate value.","jir_summary":"### Overview of Capital Policy\nDaiichi Life Group resolved at its Board of Directors meeting on June 22, 2026, to issue new shares of restricted stock as part of its equity compensation scheme for directors. This aims to boost executive morale and promote sustained corporate growth. The issuance will total 743,800 shares, amounting to approximately 130 million yen. Details include restrictions on transfer periods, conditions for\u89e3\u9664, and provisions for gratuitous acquisition, ensuring long-term incentives for directors through operational implementation.\n\n### Future Outlook and Impact on Shareholders\nThe recent issuance of new shares aims to incentivize directors\u2019 shareholdings and enhance corporate value. The introduction of the scheme is expected to increase director motivation and sense of responsibility, contributing to long-term value creation. The issuance will result in a dilution of less than 0.1%, limiting the impact on existing shareholders. Going forward, we will ensure proper operation and transparency of the scheme to maximize shareholder value.","jir_financial_highlights":"Number of Shares Issued (RS): 269,800 shares (New issuance)\nNumber of Shares Issued (PSU): 473,000 shares (New issuance)\nTotal Amount Issued: Unknown (Unknown)","jir_category":"","jir_hashtags":"#DaiichiLifeGroup, #IRRelated, #JapanStocks","jir_key_figures":"Number of Shares Issued (RS): 269,800 shares\nNumber of Shares Issued (PSU): 473,000 shares\nTotal Amount Issued: Unknown","jir_meta_title":"[Daiichi Life Group] New Share Issuance under Equity Compensation Program | June 22, 2026","jir_meta_description":"Daiichi Life Group approved the issuance of new shares as part of its equity compensation scheme for directors on June 22, 2026. The plan aims to raise approximately 130 million yen and strengthen long-term incentives.","jir_og_title":"[Daiichi Life Group] New Share Issuance under Equity Compensation Program | June 22, 2026","jir_og_description":"Daiichi Life Group issued new shares as part of its equity compensation scheme for directors, aiming to enhance corporate value and long-term incentives.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":6871,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_option","footnotes":""},"sector":[],"importance":[],"class_list":["post-67197","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n